Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 71610-289

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 250 mg (71610 0289 30)

Bottle Label 250 mg (71610 0289 30)
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
The text describes a figure labeled "Figure 1" featuring the effects of Divalproex Sodium Delayed-Release Tablets compared to a placebo in reducing the CPS rate. The figure shows that the medication can result in a 50% improvement in CPS rate in patients.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
The text corresponds to part of a figure showing the reduction in CPS rate for high and low dose Divalproex Sodium Delayed-Release Tablets. It indicates the percentage of patients who improved, had no change, or worsened. No further information is given.*
FDA Label Image

Fig-3 (Divalproex Fig3)

Fig-3 (Divalproex Fig3)
This is a list of numerical values followed by the name of a medication: Divalproex Sodium Extended-Release Tablets. No additional information or context is provided.*
FDA Label Image

Chemical Structure (Divalproex Str)

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.